Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Balance Medical Technology CoSHSE:688198 -1.01%86 5-Year Yield-on-Cost % is 8.22 as of Sep. 08, 2026, which is 181% above its 10-year median of 2.93. GuruFocus rates SHSE:688198 with a GF Score™ of 86/100 and a GF Value™ of ¥168.04 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Beijing Balance Medical Technology Co ranks better than 88.54% on this metric.
SHSE:688198's 5-Year Yield-on-Cost % is ranked better than 88.54% of 314
companies
in the Medical Devices & Instruments industry
Industry Median: 2.455
vs SHSE:688198: 8.22
Beijing Balance Medical Technology Co (SHSE:688198) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Beijing Balance Medical Technology Co 5-Year Yield-on-Cost % Related Terms
SHSE:688198 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Balance Medical Technology Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost % falls into.
Beijing Balance Medical Technology Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Beijing Balance Medical Technology Co (SHSE:688198) has a 5-Year Yield-on-Cost % of 8.22 as of Sep. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Balance Medical Technology Co and its competitors. This is 181% above median its historical median of 2.93. Over the past decade, Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost % has ranged from 0.50 to 8.22. According to the industry distribution chart, Beijing Balance Medical Technology Co ranks #36 out of 314 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost % too high?
Beijing Balance Medical Technology Co's current 5-Year Yield-on-Cost % of 8.22 is 181% above median its 10-year median of 2.93. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 8.22. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.46. Beijing Balance Medical Technology Co's value of 8.22 is 234.8% above this industry median. Based on the distribution chart, Beijing Balance Medical Technology Co ranks #36 out of 314 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Balance Medical Technology Co ranks #36 out of 314 companies for 5-Year Yield-on-Cost %. This places Beijing Balance Medical Technology Co in the top 12% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.46. Beijing Balance Medical Technology Co's value of 8.22 is 234.8% above this benchmark. Historically, Beijing Balance Medical Technology Co's own 5-Year Yield-on-Cost % has ranged from 0.50 to 8.22 over the past decade. While the company's 10-year median is 2.93 vs. the industry median of 2.46, Beijing Balance Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.46, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Balance Medical Technology Co's current 5-Year Yield-on-Cost % of 8.22 is 234.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Balance Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Balance Medical Technology Co's current 5-Year Yield-on-Cost % is 8.22, which is 181% above median its own 10-year median of 2.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥168.04, compared to a current price of ¥70.26 — trading 58.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 8.22, which is 181% above median its 10-year median of 2.93 and 234.8% above the Medical Devices & Instruments industry median of 2.46. Beijing Balance Medical Technology Co's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current 5-Year Yield-on-Cost % is 8.22 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥70.26 is trading 58.2% below its estimated GF Value™ of ¥168.04.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
5-Year Yield-on-Cost %: 8.22 (181% above median its 10-year median of 2.93)
GF Value™: ¥168.04 vs. price of ¥70.26 (58.2% below fair value)
Industry Position: 234.8% above the Medical Devices & Instruments median (#36 of 314)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
86GF Score
Get the complete analysis for SHSE:688198
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
